Procalcitonin assay trial: part of initiative to reduce exposure to antibiotics

The trial of a new procalcitonin assay from Beckman Coulter Diagnostics, undertaken in Portsmouth, is part of an initiative to reduce exposure to antimicrobial agents without a negative impact on patient survival.

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.